Document Detail

Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
MedLine Citation:
PMID:  17765365     Owner:  NLM     Status:  MEDLINE    
Anthrolysin O (ALO) is a toxin produced by Bacillus anthracis, the causative agent of anthrax. It is a member of the cholesterol-dependent cytolysin (CDC) group of toxins, many of which are potential vaccine candidates that protect against their producing organisms. Pore formation by ALO was studied by transmission electron microscopy and pores were found to be consistent with those formed by other members of this toxin family. We constructed and characterised a novel genetic toxoid of anthrolysin O, Delta6mALO, which was able to bind to cells but was incapable of pore-formation or haemolysis. The capacity of the haemolytic and non-haemolytic forms of ALO to protect against challenge with the toxin or B. anthracis was determined. Immunisation with both active and non-haemolytic forms of ALO elicited protection against lethal i.v. challenge with ALO but neither was protective against B. anthracis in a murine i.p. challenge model. Immunisation with another CDC, pneumolysin, did not confer cross-protection against challenge with ALO. Histopathological investigation following lethal i.v. challenge with ALO revealed acute pathology in the lungs with occlusion of alveolar vessels by fibrin deposits.
Graeme J M Cowan; Helen S Atkins; Linda K Johnson; Richard W Titball; Tim J Mitchell
Related Documents :
24557745 - Understanding hpv vaccination among latino adolescent girls in three u.s. regions.
1508685 - Solid-phase synthesis of the nucleopeptide fragment h-asp-ser[paaagtaagcc]-glu-oh from ...
21461375 - Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost reg...
23739535 - A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats.
21658665 - Adult immunizations: update on recommendations.
24741915 - Opinions of employees of the national institute of public health--national institute of...
Publication Detail:
Type:  Journal Article     Date:  2007-08-09
Journal Detail:
Title:  Vaccine     Volume:  25     ISSN:  0264-410X     ISO Abbreviation:  Vaccine     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-10-01     Completed Date:  2007-12-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406899     Medline TA:  Vaccine     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  7197-205     Citation Subset:  IM    
Division of Infection and Immunity, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anthrax / immunology,  prevention & control*
Anthrax Vaccines / genetics,  immunology*,  toxicity
Antigens, Bacterial / toxicity*
Antitoxins / blood
Bacillus anthracis / immunology*
Bacterial Proteins / genetics,  immunology*,  toxicity*
Bacterial Toxins / toxicity*
Erythrocytes / drug effects,  ultrastructure
Immunoglobulin G / blood
Lung / pathology
Membrane Glycoproteins / genetics,  immunology*,  toxicity*
Microscopy, Electron, Transmission
Poisoning / immunology,  prevention & control*
Survival Analysis
Toxoids / genetics,  immunology*,  toxicity
Reg. No./Substance:
0/Anthrax Vaccines; 0/Antigens, Bacterial; 0/Antitoxins; 0/Bacterial Proteins; 0/Bacterial Toxins; 0/Immunoglobulin G; 0/Membrane Glycoproteins; 0/Toxoids; 0/anthrax toxin; 0/anthrolysin O, Bacillus anthracis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in t...
Next Document:  Kinetics of radiocesium released from contaminated soil by fertilizer solutions.